Evidence map›Paper›PMID 17194757›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2007

Functionally important glycosyltransferase gain and loss during catarrhine primate emergence.

Chihiro Koike, Monica Uddin, Derek E Wildman, Edward A Gray, Massimo Trucco, Thomas E Starzl, Morris Goodman

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Association between ABO blood groups and COVID-19 infection, severity and demise: A systematic review and meta-analysis.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2020
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Observational
  8. Review
  9. Infection withVaccines · 2020
    Article
  10. Review
  11. Article
  12. Diagnosis and Management of Patients with the α-Gal Syndrome.The journal of allergy and clinical immunology. In practice · 2020
    Review
  13. Article
  14. Galactose α-1,3-galactose phenotypes: Lessons from various patient populations.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2019
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Anaphylaxis to the carbohydrate side chain alpha-gal.Immunology and allergy clinics of North America · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chihiro KoikeDepartment of Surgery and Thomas E. Starzl Transplantation Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Monica Uddin
Derek E Wildman
Edward A Gray
Massimo Trucco
Thomas E Starzl
Morris Goodman
University of Pittsburgh · USWayne State University · USChildren's Hospital of Pittsburgh · US

Funding

GENE MODIFIED CLONED PIGSR01DK064207 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAI, YIFAN · 2003 to 2005
$836k
Intramural NIH HHSNIDDK NIH HHS R01 DK064207NIDDK NIH HHS R01DK64207
6 · The paper itself

Abstract

A glycosyltransferase, alpha1,3galactosyltransferase, catalyzes the terminal step in biosynthesis of Galalpha1,3Galbeta1-4GlcNAc-R (alphaGal), an oligosaccharide cell surface epitope. This epitope or antigenically similar epitopes are widely distributed among the different forms of life. Although abundant in most mammals, alphaGal is not normally found in catarrhine primates (Old World monkeys and apes, including humans), all of which produce anti-alphaGal antibodies from infancy onward. Natural selection favoring enhanced resistance to alphaGal-positive pathogens has been the primary reason offered to account for the loss of alphaGal in catarrhines. Here, we question the primacy of this immune defense hypothesis with results that elucidate the evolutionary history of GGTA1 gene and pseudogene loci. One such locus, GGTA1P, a processed (intronless) pseudogene (PPG), is present in platyrrhines, i.e., New World monkeys, and catarrhines but not in prosimians. PPG arose in an early ancestor of anthropoids (catarrhines and platyrrhines), and GGTA1 itself became an unprocessed pseudogene in the late catarrhine stem lineage. Strong purifying selection, denoted by low nonsynonymous substitutions per nonsynonymous site/synonymous substitutions per synonymous site values, preserved GGTA1 in noncatarrhine mammals, indicating that the functional gene product is subjected to considerable physiological constraint. Thus, we propose that a pattern of alternative and/or more beneficial glycosyltransferase activity had to first evolve in the stem catarrhines before GGTA1 inactivation could occur. Enhanced defense against alphaGal-positive pathogens could then have accelerated the replacement of alphaGal-positive catarrhines by alphaGal-negative catarrhines. However, we emphasize that positively selected regulatory changes in sugar chain metabolism might well have contributed in a major way to catarrhine origins.

Indexed as

Evolution, MolecularAnimalsBase SequenceCatarrhiniDNA PrimersGalactosyltransferasesHumansModels, GeneticMolecular Sequence DataPhylogenyPseudogenesTime Factorsbeta-D-galactosyl-N-acetylglucosaminylglycopeptide alpha-1,3-galactosyltransferaseDNA PrimersGalactosyltransferases

Identifiers

PMID17194757
PMCPMC1766424
OpenAlexW2103370565

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.